Pfizer’s ‘Head-and-Shoulders’ Top Is a Bad Sign

Pfizer has reached the end of its distribution period, and PFE stock has broken down in a reversal to a new downtrend. More 

Why the $116 Billion PFE-AZN Deal is Dead in the Water

The Pfizer (PFE) - AstraZeneca (AZN) merger has been one of the most heavily anticipated deals of the year. And it's going to fall through. More 

Hottest Healthcare Stocks Now – CMN LH PFE COV

Healthcare stocks declined 0.6% on Wall Street today. More 

Life Expectancy Rises: 5 Best Stocks to Buy

Life expectancy for U.S. babies born in 2012 hit a record high at 78.8 years. Here are the 5 best stocks to buy to invest in longevity. More 

Pfizer (PFE) Aims at Women in New Viagra Ads

Pfizer is has released a new ad for Viagra that targets women in what is likely an effort to reach out to the other group affected by ED. More 

Top 10 Dow Dividend Stocks for October

Income investors hoping for some exposure to capital appreciation should consider these stable blue-chip heavyweights More 

Want to Invest in Biotech Stocks? Learn the Rules First.

Even in the good conditions of the biotech market today, investors should do due diligence and find reliable sources when picking biotech stocks. More